In July 2018, the US Food and Drug Administration (FDA) issued a consumer warning about the use of carbon dioxide (CO2) laser therapy for vaginal cosmetic procedures or ‘vaginal rejuvenation’. The FDA stated that “These products have serious risks and don’t have adequate evidence to support their use for these purposes. We are deeply concerned women are being harmed.”
The first randomised clinical trial involving vaginal laser for treating menopausal vaginal symptoms was published last year (2018). The study reported some benefits with laser treatment. But concerns were raised regarding increased vaginal pain in the group of women using laser treatment.
More extensive clinical research is required before it is known whether laser is safe and effective for treating menopausal vaginal symptoms.